Is MFS Global Equity A Fund (MWEFX) Worth Another Look?

MFS Global Equity A (MWEFX) a Zacks Rank #3 (Hold) was incepted in December 1986 and is managed by Massachusetts Financial Services Company. The fund's investment objective is to seek capital appreciation. The fund invests, under normal market conditions, at least 65% of its net assets in common stocks and equity-related securities, such as preferred stock, convertible securities and depositary receipts, of U.S. and foreign (including emerging market) issuers. Under normal market conditions, the fund invests in at least three different countries, one of which is the United States. The fund generally seeks to purchase securities of companies with relatively large market capitalizations relative to the market in which they are traded.

This fund, as of the last filing, allocates their fund in five major groups; Foreign Stock, Large Growth, Small Growth, Foreign Bond and Large Value. Further, as of the last filing, Thermo Fisher Scientific (NYSE:TMO), Nestlé and Bayer (DE:BAYGN) were the top holdings for MWEFX.

MFS Global Equity A, managed by MFS, carries an expense ratio of 1.22%. Moreover, MWEFX requires a minimal initial investment of $1,000.

MWEFX has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 1, 3, 5 year benchmarks; 1 year 1.27%, 3 year 3.88% and 5 year 10.34%. To see how this fund performed compared in its category and other #1 and #2 Ranked Mutual Funds, please click here.

MWEFX’s performance, as of the last filing, when compared to funds in its category was in the top 46% in 1 year, top 31% over the past 3 years, and in the 22% over the past 5 years.

About Zacks Mutual Fund Rank

By applying the Zacks Rank to mutual funds, investors can find funds that not only outpaced the market in the past but are also expected to outperform going forward. Pick the best mutual funds with the Zacks Rank.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>